β-lactamases involved in resistance to broad-spectrum cephalosporins in escherichia coli and Klebsiella spp. clinical isolates collected between 1994 and 1996, in Barcelona (Spain)

Journal of Antimicrobial Chemotherapy

Volumn 49, Issue 6, 2002, Pages 989-997

  Sabaté, Montserrat ^a   Miró, Elisenda ^a   Navarro, Ferran ^a   Vergés, Clara ^a   Aliaga, Roxana ^a   Mirelis, Beatriz ^a   Prats, Guillermo ^a  

^a HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; AZTREONAM; BACTERIAL ENZYME; BETA LACTAMASE; CEFALORIDINE; CEFAZOLIN; CEFOTAXIME; CEFOXITIN; CEFTAZIDIME; CEFTRIAXONE; CEPHALOSPORIN DERIVATIVE; CEPHAMYCIN DERIVATIVE; CLAVULANIC ACID; KANAMYCIN; MONOBACTAM; NALIDIXIC ACID; PIPERACILLIN; TICARCILLIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL CHROMOSOME; BACTERIAL STRAIN; BACTERIUM ISOLATE; CONTROLLED STUDY; ENTEROBACTERIACEAE; ENZYME ASSAY; ENZYME SYNTHESIS; ESCHERICHIA COLI; GENE INDUCTION; HUMAN; INCIDENCE; KLEBSIELLA OXYTOCA; KLEBSIELLA PNEUMONIAE; PLASMID; SPAIN; DRUG EFFECT; ENTEROBACTER INFECTION; ENZYMOLOGY; ISOLATION AND PURIFICATION; KLEBSIELLA; MICROBIOLOGY; PHYSIOLOGY;

BETA-LACTAMASES; CEPHALOSPORIN RESISTANCE; CEPHALOSPORINS; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; HUMAN; KLEBSIELLA; SPAIN; SUPPORT, NON-U.S. GOV'T; HUMANS;

EID: 0035992135     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/dkf057     Document Type: Article

References (57)

1. Prevalence and mechanism of resistance to 'third-generation' cephalosporins in clinically relevant isolates of Enterobacteriaceae from 43 hospitals in the UK, 1990-1991
2. A functional classification scheme for β-lactamases and its correlation with molecular structure
3. β-Lactamases in laboratory and clinical resistance
4. Close amino acid sequence relationship between the new plasmid-mediated extended-spectrum β-lactamase MEN-1 and chromosomally encoded enzymes of Klebsiella oxytoca
5. A new plasmidic cefotaximase from patients infected with Salmonella typhimurium
6. A new plasmidic cefotaximase in a clinical isolate of Escherichia coli
7. Sequences of β-lactamase genes encoding CTX-M-1 (MEN-1) and CTX-M-2 and relationship of their sequences with those of other β-lactamases
8. A novel plasmid-mediated extended-spectrum β-lactamase not derived from TEM- or SHV-type enzymes
9. CTX-M-5, a novel cefotaxime-hydrolyzing β-lactamase from an outbreak of Salmonella typhimurium in Latvia
10. A plasmid-mediated β-lactamase conferring resistance to cefotaxime in a Salmonella typhimurium clone found in St Petersburg, Russia
11. Two novel plasmid-mediated cefotaxime-hydrolyzing β-lactamases (CTX-M-5 and CTX-M-6) from Salmonella typhimurium
12. Sequence of the gene encoding a plasmid-mediated cefotaxime-hydrolyzing class A β-lactamase (CTX-M-4): Involvement of serine 237 in cephalosporin hydrolysis
13. Cefotaxime-resistant Enterobacteriaceae isolates from a hospital in Warsaw, Poland: Identification of a new CTX-M-3 cefotaxime-hydrolyzing β-lactamase that is closely related to the CTX-M-1/MEN-1 enzyme
14. Cloning and sequence of the gene encoding a cefotaxime-hydrolysing class A β-lactamase isolated from Escherichia coli
15. Cloning and sequencing of the gene encoding TOHO-2, a class A β-lactamase preferentially inhibited by tazobactam
16. Cloning and sequence of the gene encoding a novel cefotaxime-hydrolyzing β-lactamase (CTX-M-9) from Escherichia coli in Spain
17. Emergence of resistance to third-generation cephalosporins amongst Salmonella typhimurium isolates in Greece: Report of the first three cases
18. Escherichia coli producing a cephamycinase (CMY-2) from a patient from the Libyan-Tunisian border region
19. Characterization of the plasmidic β-lactamase CMY-2, which is responsible for cephamycin resistance
20. BIL-1, a plasmid-mediated class C β-lactamase gene in Escherichia coli BS
21. Transferable cefoxitin resistance in enterobacteria from Greek hospitals and characterization of a plasmid-mediated group 1 β-lactamase (LAT-2)
22. A plasmid-mediated CMY-2 β-lactamase from an Algerian clinical isolate of Salmonella senftenberg
23. LAT-1) found in Klebsiella pneumoniae
24. Imipenem resistance in Klebsiella pneumoniae is associated with the combination of ACT-1, a plasmid-mediated AmpC β-lactamase, and the loss of an outer membrane protein
25. Novel plasmid-mediated β-lactamase (MIR-1) conferring resistance to oxyimino- and α-methoxy β-lactams in clinical isolates of Klebsiella pneumoniae
26. Salmonella enteritidis: AmpC plasmid-mediated inducible β-lactamase (DHA-1) with an ampR gene from Morganella morganii
27. CMY-1gene and its relationship with other β-lactamase genes
28. A novel class C β-lactamase (FOX-2) in Escherichia coli conferring resistance to cephamycins
29. Gene sequence and biochemical characterization of FOX-1 from Klebsiella pneumoniae, a new AmpC-type plasmid-mediated β-lactamase with two molecular variants
30. Plasmid-mediated AmpC-type β-lactamase isolated from Klebsiella pneumoniae confers resistance to broad-spectrum β-lactams, including moxalactam
31. Characterization of FOX-3, an AmpC-type plasmid-mediated β-lactamase from an Italian isolate of Klebsiella oxytoca
32. Performance Standards for Antimicrobial Susceptibility Testing-Sixth Informational Supplement: Approved Standard M100-S6
33. Emergence of clinical Escherichia coli isolates with decreased susceptibility to ceftazidime and synergic effect with co-amoxiclav due to SHV-1 hyperproduction
34. β-Lactamases: Determination of their isoelectric points
35. Activities of imipenem and cephalosporins against clonally related strains of Escherichia coli hyperproducing chromosomal β-lactamase and showing altered porin profiles
36. Incidencia de betalactamasas de espectro ampliado en Escherichia coli en un hospital universitario durante 1994-96
37. Detection of genes coding for extended-spectrum SHV betalactamases in clinical isolates by a molecular method, and comparison with the E test
38. Salmonella enterica serovar Virchow with CTX-M like β-lactamase around Spain
39. Bases of variation in resistance to β-lactams in Klebsiella oxytoca isolates hyperproducing K1 β-lactamase
40. ampC cephalosporinase of Escherichia coli K-12 has a different evolutionary origin from that of β-lactamase of the penicillinase type
41. The E. coli beta-lactamase attenuator mediates growth rate-dependent regulation
42. Molecular basis of AmpC hyperproduction in clinical isolates of Escherichia coli
43. Isolation and characterization of DNA repetitions carrying the chromosomal β-lactamase gene of Escherichia coli K12
44. Mutations in the ampC promoter of Escherichia coli isolates resistant to oxyiminocephalosporins without extended spectrum β-lactamase production
45. Does high level production of SHV-type penicillinases confer resistance to ceftazidime in Enterobacteriaceae?
46. High-level expression of chromosomally encoded SHV-1 β-lactamase and an outer membrane protein change confer resistance to ceftazidime and piperacillin-tazobactam in a clinical isolate of K. pneumoniae
47. Resistance to ticarcillin-potassium clavulanate among clinical isolates of the family Enterobacteriaceae: Role of PSE-1 β-lactamase and high levels of TEM-1 and SHV-1 and problems with false susceptibility in disc-diffusion tests
48. Are SHV β-lactamases universal in Klebsiella pneumoniae?
49. Klebsiella pneumoniae strains moderately resistant to ampicillin and carbenicillin: Characterization of a new β-lactamase
50. β-Lactamases in Shigella flexneri isolates from Hong Kong and Shanghai and a novel OXA-1-like β-lactamase, OXA-30
51. oxy-2
52. Variability of chromosomally encoded β-lactamases from Klebsiella oxytoca
53. A survey of β-lactamases from 618 isolates of Klebsiella spp
54. Rarity of transferable β-lactamase production by Klebsiella species
55. Estudio multicéntrico de la resistencia a la cefotaxima durante el año 1991: Detección y caracterización de nuevas β-lactamasas de espectro ampliado
56. Primera epidemia española de resistencia plasmídica a cefalosporinas de tercera generación: Implicación de SHV-2
57. CMY-2-producing Salmonella enterica, Klebsiella pneumoniae, Klebsiella oxytoca, Proteus mirabilis and Escherichia coli strains isolated in Spain (October 1999-December 2000)